164. Oculocutaneous albinism Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 16 Drugs : 44 - (DrugBank : 27) / Drug target genes : 30 - Drug target pathways : 137

Oculocutaneous albinism and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)